CSL to manufacture and supply University of Queensland and Oxford University vaccine candidates for Australia
7 September 2020 Heads of Agreement signed between CSL and the Australian Government to supply 51 million doses of University of Queensland vaccine to Australia, with first doses scheduled for release from mid-2021 following successful clinical trials. Heads…
Snoretox receives “Barrier to Innovation” Waiver from FDA (Center for Veterinary Medicine) for Innovative Medical Breakthrough Therapy.
Date Posted: 7 September 2020 4 September 2020 Drug Solution for Hypotonic Muscle Disorders. Snoretox receives “Barrier to Innovation” Waiver from FDA (Center for Veterinary Medicine) for Innovative Medical Breakthrough Therapy. Snoretox Pty Ltd has invented and patented…
$4.1 million raised in fully allocated AdAlta Entitlement Offer
7 September 2020 Highlights $4.1 million raised in fully allocated Entitlement Offer Total of $8.1 million raised across Placement and Entitlement Offer Majority of funds from existing shareholders Provides funds to progress growth strategy through 2021, adding value…
Australia Secures Onshore Manufacturing Agreements For Two COVID-19 Vaccines
7 September 2020 A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successful, following a $1.7 billion supply and production agreement between the Australian Government and pharmaceutical companies. Under the agreement,…
Opyl achieves major milestone with AI platform that forecasts COVID19 clinical trial outcomes
3 September 2020 Opyl’s technology improves clinical trials by identifying the drugs, vaccines, diagnostics or medical devices most likely to succeed Opyl is applying its platform towards COVID-19 therapeutic and vaccine programs in clinical studies to predict likelihood…
$0.75M Funding Awarded to LBT Innovations For APAS®-AMR Analysis Module
3 September 2020 Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce the Company has been awarded funding under MTPConnect’s Biomedical…
The answer to self-discovery is found at Cartherics
3 September 2020 Originally posted by Catherics. For new recruit Walid Azar, it was about finding his calling. As Walid Azar settles into his new dual role as Senior Research Fellow and Deputy Lab Manager at Cartherics, he…
Australian biomedical research efforts boosted by $10.4 million
3 September 2020 Congratulations to all BioMelbourne Network member organisations that received funding, including BARD1 Life Sciences Limited, The Florey Institute of Neuroscience and Mental Health, Dimerix Bioscience Pty Ltd, LBT Innovations Ltd, Starpharma Holdings Ltd and University of Melbourne. Learn more about the funded projects.…
‘Chance favours the prepared mind’ – Frederico Calhabeu has followed Louis Pasteur’s advice from France to Cartherics
3 September 2020 Originally posted by Catherics. When considering whether to continue his translational research program at the Australian Regenerative Medicine Institute (ARMI), Frederico Calhabeu had a quick chat with Silvio Tiziani, Director, External Strategy and Planning at…
Protein discovery could improve type 2 diabetes treatment
3 September 2020 A world first discovery of how a protein works in the liver could lead to a more effective type 2 diabetes drug. The researchers say such treatments will be more important than ever given that…
Good News from Cartherics: New funding from the Federal Entrepreneurs Programme will boost the company’s R&D efforts
3 September 2020 “It’s good to get new money into Cartherics,” says the Cartherics’ Chief Scientific Officer Richard Boyd. He adds that the AU$120,000 in grant funding is particularly welcome as all Melbourne-based research and development (R&D) groups…
3 new La Trobe COVID-19 projects begin
3 September 2020 Release date 28 August 2020 La Trobe University researchers are rapidly embarking on ways to improve community health and wellbeing as a result of the COVID-19 pandemic, with new targeted grants from La Trobe, Medibank…
